当前位置：首页 > 文献互助 > 互助详情

Hyperthermic intraperitoneal chemotherapy after interval cytoreductive surgery for patients with advanced-stage ovarian cancer who had received neoad‐ juvant chemotherapy复制

用户Lz2LyWF0h8HA 5个月前 208 10 已关闭

DOI: 10.1001/jamasurg.2023.3944复制

文献链接:复制

其他信息:

上一篇：Survival After Hyperthermic Intraperitoneal Chemotherapy and Primary or Interval Cytoreductive Surgery in Ovarian Cancer

下一篇：Review Article: Immunotherapy for Pediatric Malignancies: Benefits and Beyond

互助时间线

2026-02-25 15:57:28 [关闭求助]

楼主用户Lz2LyWF0h8HA关闭了求助

2026-02-25 15:22:33 [发起求助]

最新发布的求助

Why studying females reveals more about aging: The reproductive resilience hypothesis for the evolution of sex-specific aging 4分钟前
Structure and Properties of Cs7(H4PO4)(H2PO4)8: A New Superprotonic Solid Acid Featuring the Unusual Polycation (H4PO4)+ 21分钟前
Synthesis of 1,4-diketones by fluoride-catalysed Michael addition and supported permanganate oxidation 30分钟前
13. Experiments on the synthesis of substances related to the sterols. Part XIV. A simple synthesis of certain octalones and ketotetrahydrohydrindenes which may be of angle-methyl-substituted type. A theory of the biogenesis of the sterols 36分钟前
The Preparation of Derivatives of Chrysene by Means of the Robinson-Mannich Base Synthesis of Unsaturated Ketones 45分钟前
Integrated bundled measures could halve reactive nitrogen losses and reach net-zero greenhouse gas emissions in global livestock systems 49分钟前
Synthesis and Resolution of Phenyl-α-(β-methoxynaphthyl)-aminomethane 49分钟前
XunZi, an AI biologist, reveals disease-modifying targets 1小时前
The Pharmacology of CAR T Cell Therapy for Autoimmune Disease 1小时前
Telitacicept for IgA Nephropathy — Interim Analysis of a Phase 3 Trial 1小时前
Discovery of PAR2 antagonists through fragment molecular orbital-based hotspot analysis and allosteric sodium site dynamics simulations 2小时前
Factors influencing adjuvant treatment decision making among Chinese patients with hepatocellular carcinoma (HCC): Results of a patient survey. 2小时前

wispass工作室 Copyright © 蜀ICP备2024051606号-2 www.wispass.com